We are live on ! Find out more
GCA

Greenwood Capital Associates Portfolio holdings

AUM $1.02B
1-Year Est. Return 28.26%
This Fund
S&P 500
This Quarter Est. Return
-0.09%
1 Year Est. Return
+28.26%
3 Year Est. Return
+81.29%
5 Year Est. Return
+95.78%
10 Year Est. Return
+421.94%
AUM
$908M
AUM Growth
-$13.3M
Cap. Flow
+$7.68M
Cap. Flow %
0.85%
Top 10 Hldgs %
25.34%
Holding
311
New
55
Increased
103
Reduced
113
Closed
25

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$5.82M
2
P
Everpure Inc
P
+$5.56M
3
DOW icon
Dow Inc
DOW
+$5M
4
ADBE icon
Adobe
ADBE
+$4.81M
5
TMUS icon
T-Mobile US
TMUS
+$4.81M

Top Sells

Rank Stock Value
1
ASML icon
ASML
ASML
+$7.88M
2
APH icon
Amphenol
APH
+$6.34M
3
ALB icon
Albemarle
ALB
+$6.02M
4
SYK icon
Stryker
SYK
+$5.98M
5
EOG icon
EOG Resources
EOG
+$5.15M

Sector Composition

Rank Sector Weight
1 Technology 17.64%
2 Healthcare 8.62%
3 Financials 8.08%
4 Communication Services 6.27%
5 Consumer Discretionary 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IGV icon
301
iShares Expanded Tech-Software Sector ETF
IGV
$14.8B
-2,065
Closed -$218K
IP icon
302
International Paper
IP
$21.8B
-27,960
Closed -$1.1M
LAZ icon
303
Lazard
LAZ
$4.24B
-20,139
Closed -$978K
ORCL icon
304
Oracle
ORCL
$442B
-14,498
Closed -$2.83M
PRU icon
305
Prudential Financial
PRU
$42.3B
-19,295
Closed -$2.18M
RF icon
306
Regions Financial
RF
$26.9B
-74,062
Closed -$2.01M
SHV icon
307
iShares 0-1 Year Treasury Bond ETF
SHV
$20.6B
-2,519
Closed -$277K
SNV
308
DELISTED
Synovus
SNV
-12,809
Closed -$641K
SYK icon
309
Stryker
SYK
$133B
-17,001
Closed -$5.98M
UTHR icon
310
United Therapeutics
UTHR
$21.9B
-1,185
Closed -$577K
WRB icon
311
W.R. Berkley
WRB
$25.9B
-5,993
Closed -$420K

Similar funds

Greenwood Capital Associates's Q1 2026 Portfolio in Review

As of Q1 2026, Greenwood Capital Associates held 311 positions worth $908M, down 1.4% from $921M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Greenwood Capital Associates's Q1 2026 filing shows 55 new, 103 increased, 113 reduced and 25 closed positions. Its largest new stake was Everpure Inc: 82,029 shares worth $4.84M. The largest sale was ASML, an estimated $7.88M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

  • Greenwood Capital Associates's largest Q1 2026 buy was Everpure Inc: 82,029 shares worth $4.84M.
  • Greenwood Capital Associates added most to Amgen in Q1 2026, an estimated $5.82M increase.
  • Greenwood Capital Associates's biggest Q1 2026 reduction was iShares MSCI China ETF, cutting an estimated $4.71M.
  • Greenwood Capital Associates fully exited ASML in Q1 2026, selling an estimated $7.88M.
  • Greenwood Capital Associates's ten largest holdings make up 25% of its $908M portfolio in Q1 2026.
  • Greenwood Capital Associates opened 55 new positions and closed 25 in Q1 2026.
  • Greenwood Capital Associates's portfolio value fell 1.4% quarter-over-quarter to $908M.

Based on Greenwood Capital Associates's 13F filing for Q1 2026, filed 29 Apr 2026.